SCHEMBL17201502

SCHEMBL17201502

CC(C)(C)OC(=O)c1ccc(-c2cc(S(C)(=O)=O)cnn2)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
GPR119 Q8TDV5 10/20 0.35
ALDH1A1 P00352 2/20 0.34
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
ESR1 P03372 1/20 0.33
ESRRG P62508 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201690 0.83 CTSS (0.38) CTSSCTSKALDH1A1HSD17B1HSD17B2
SCHEMBL17201588 0.81 ALDH1A1 (0.36) ALDH1A1RAB9AHDAC1LMNA
SCHEMBL17201521 0.80 ALDH1A1 (0.34) ALDH1A1HSD17B1HSD17B2
Trifluoroacetic Acid SCHEMBL17201689 0.79 CTSS (0.39) CTSSCTSKALDH1A1HSD17B1HSD17B2
SCHEMBL17201629 0.78 ALDH1A1 (0.33) ALDH1A1
SCHEMBL17201507 0.69 ALDH1A1 (0.35) CTSSCTSKALDH1A1NPC1RAB9A
SCHEMBL8549434 0.69 TSHR (0.44) ALDH1A1CA12CA1CA2CA9
SCHEMBL17201531 0.66 GRM6 (0.35) ALDH1A1HSD17B1HSD17B2HDAC4HDAC1
SCHEMBL17201516 0.65 ERN1 (0.46) CTSSCTSKALDH1A1NPC1RAB9A
SCHEMBL14100232 0.65 AAK1 (0.41) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725459-B2 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I GRUNENTHAL GMBH (DE) 2017-08-08 US disclosed
EP-3140309-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2017-03-15 EP disclosed
WO-2015161928-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 WO disclosed
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I CTSK, OPRK1, CAT CTSS 33/4885CTSK 1/4885GPR119 1680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.